All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

Lobbying for CERUS CORPORATION

Filing Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Budget/Appropriations

H.R.____/S.____ Department of Defense Appropriations Bill, 2027, Title VI, all provisions related to blood safety. H.R.____/S.____ Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027 - Title II, all provisions related to blood safety.

Defense

H.R.____/S.____ National Defense Authorization Act, 2027, Title XIV, all provisions related to blood safety.

Health Issues

Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.